
SUPERSTRING CAPITAL MANAGEMENT LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | SVRA | 1.59M | $8.66M |
![]() | CABA | 1.07M | $2.87M |
![]() | SMMT | 893K | $16.93M |
![]() | VIR | 731K | $6.55M |
![]() | URGN | 387K | $6.96M |
![]() | ACRS | 366K | $1.37M |
![]() | IMVT | 358K | $8.88M |
![]() | DFTX | 351K | $6.64M |
![]() | ARVN | 313K | $3.31M |
![]() | ZLAB | 276K | $5.19M |
![]() | TSHA | 258K | $1.15M |
![]() | TRVI | 252K | $3.00M |
![]() | BMEA | 250K | $382.50K |
![]() | COGT | 225K | $8.67M |
![]() | GMAB | 197K | $5.28M |
![]() | MPLT | 192K | $3.91M |
![]() | CLDX | 180K | $5.71M |
![]() | SION | 141K | $5.65M |
![]() | TARA | 121K | $632.79K |
![]() | IPSC | 119K | $269.64K |

Savara Inc.
SVRA
Shares Held
1.59M
Value
$8.66M

Cabaletta Bio, Inc.
CABA
Shares Held
1.07M
Value
$2.87M

Summit Therapeutics Inc.
SMMT
Shares Held
893K
Value
$16.93M

Vir Biotechnology, Inc.
VIR
Shares Held
731K
Value
$6.55M

UroGen Pharma Ltd.
URGN
Shares Held
387K
Value
$6.96M

Aclaris Therapeutics, Inc.
ACRS
Shares Held
366K
Value
$1.37M

Immunovant, Inc.
IMVT
Shares Held
358K
Value
$8.88M

Definium Therapeutics, Inc.
DFTX
Shares Held
351K
Value
$6.64M

Arvinas, Inc.
ARVN
Shares Held
313K
Value
$3.31M

Zai Lab Limited
ZLAB
Shares Held
276K
Value
$5.19M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
258K
Value
$1.15M

Trevi Therapeutics, Inc.
TRVI
Shares Held
252K
Value
$3.00M

Biomea Fusion, Inc.
BMEA
Shares Held
250K
Value
$382.50K

Cogent Biosciences, Inc.
COGT
Shares Held
225K
Value
$8.67M

Genmab A/S
GMAB
Shares Held
197K
Value
$5.28M

MapLight Therapeutics, Inc.
MPLT
Shares Held
192K
Value
$3.91M

Celldex Therapeutics, Inc.
CLDX
Shares Held
180K
Value
$5.71M

Sionna Therapeutics, Inc.
SION
Shares Held
141K
Value
$5.65M

Protara Therapeutics, Inc.
TARA
Shares Held
121K
Value
$632.79K

Century Therapeutics, Inc.
IPSC
Shares Held
119K
Value
$269.64K
